|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Nuchal TranslucencyFrom: ATB28@aol.comWed Nov 20 17:17:30 1996
In a message dated 96-11-20 11:05:40 EST, mbriex@alienor.fr (Michel Briex) writes:
<< We use nuchal mesearement systematically at 12-13 weeks, if > 3mm
we recommend amniocentesis for Down Sd diagnostic.
If you find more than 1 or 2% you have to improve your measurement technic.
>> We also use these parameters. It is likely that measurement of fetal nuchal translucency will be incorporated into the algorithms applied to risk assessment in screening for Down syndrome in the *first* trimester (e.g., hCG, Papp-A, and nuchal fold). Of course, this doesn't address the risk for NTDs (which MSAFP addresses in the second trimester) but then again, the ultrasound should pick this up. (:-) Other modalities likely to be added soon to our screening armamentarium: (1) Maternal serum Quad test (AFP, hCG, uE3, and dimeric inhibin) for both DS and NTD. (2) Urinary beta-core (second and later first trimester) for fetal DS. Allan T. Bombard, MD Director, Reproductive Genetics Department of Obstetrics, Gynecology, and Women's Health Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:19:56 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.